RxDoctor Payments Data

Victor Wood, DO

Family Medicine · Wheeling, WVNPI 1336145630

Payments from drug & device makers

$1,677in general payments, 2019–2025

Across 100 payments — averaging $16.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$559
  • AstraZeneca$214
  • AbbVie$205
  • Pfizer$136
  • GSK$103
  • Amarin Pharma, Inc.$86
  • plus $374 from 10 others

What the payments were for

  • Food & beverage$1,65499%
  • Education$231%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,677 in reported general payments places this provider in the 75th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$233,388
Medicare patients
798
Services billed
5,414

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol55$54,218
EliquisApixaban46$48,429
JanuviaSitagliptin Phosphate38$39,964
JardianceEmpagliflozin45$37,360
OzempicSemaglutide34$36,009
XareltoRivaroxaban14$13,905
VascepaIcosapent Ethyl22$11,634
MyrbetriqMirabegron13$10,435
LinzessLinaclotide20$9,928
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen392$9,916
Stiolto RespimatTiotropium Br/Olodaterol Hcl18$8,438
Breo ElliptaFluticasone/Vilanterol18$7,094
Albuterol Sulfate HfaAlbuterol Sulfate181$5,833
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$4,885
Icosapent Ethyl18$4,671

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$214$54,21855 claims
PfizerEliquis$136$48,42946 claims
MerckJanuvia$559$39,96438 claims
Novo NordiskOzempic$79$36,00934 claims
Johnson & JohnsonXarelto$66$13,90514 claims
AbbVieLinzess$205$9,92820 claims
GSKBreo Ellipta$103$7,09418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Wheeling

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →